메뉴 건너뛰기




Volumn 58, Issue 4, 2010, Pages

Re: Florian Jentzmik, Carsten Stephan, Kurt Miller, et al. Sarcosine in urine after digital rectal examination fails as a marker in prostate cancer detection and identification of aggressive tumours. Eur Urol 2010;58:12-8

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; SARCOSINE; TUMOR MARKER;

EID: 77956555276     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eururo.2010.07.031     Document Type: Letter
Times cited : (14)

References (6)
  • 1
    • 60149091657 scopus 로고    scopus 로고
    • Metabolic profiles delineate potential role for sarcosine in prostate cancer progression
    • A. Sreekumar, L.M. Poisson, and T.M. Rajendiran Metabolic profiles delineate potential role for sarcosine in prostate cancer progression Nature 457 2009 910 914
    • (2009) Nature , vol.457 , pp. 910-914
    • Sreekumar, A.1    Poisson, L.M.2    Rajendiran, T.M.3
  • 2
    • 77952880168 scopus 로고    scopus 로고
    • Sarcosine in urine after digital rectal examination fails as a marker in prostate cancer detection and identification of aggressive tumours
    • F. Jentzmik, C. Stephan, and K. Miller Sarcosine in urine after digital rectal examination fails as a marker in prostate cancer detection and identification of aggressive tumours Eur Urol 58 2010 12 18
    • (2010) Eur Urol , vol.58 , pp. 12-18
    • Jentzmik, F.1    Stephan, C.2    Miller, K.3
  • 3
    • 77952880618 scopus 로고    scopus 로고
    • Is urinary sarcosine useful to identify patients with significant prostate cancer? the trials and tribulations of biomarker development
    • J.A. Schalken Is urinary sarcosine useful to identify patients with significant prostate cancer? The trials and tribulations of biomarker development Eur Urol 58 2010 19 20
    • (2010) Eur Urol , vol.58 , pp. 19-20
    • Schalken, J.A.1
  • 4
    • 77952883657 scopus 로고    scopus 로고
    • Reply from authors re: Jack A. Schalken. Is urinary sarcosine useful to identify patients with significant prostate cancer? the trials and tribulations of biomarker development
    • C. Stephan, F. Jentzmik, and K. Jung Reply from authors re: Jack A. Schalken. Is urinary sarcosine useful to identify patients with significant prostate cancer? The trials and tribulations of biomarker development Eur Urol 58 2010 20 21
    • (2010) Eur Urol , vol.58 , pp. 20-21
    • Stephan, C.1    Jentzmik, F.2    Jung, K.3
  • 5
    • 44949233606 scopus 로고    scopus 로고
    • Analysis of the adult human plasma metabolome
    • K.A. Lawton, A. Berger, and M. Mitchell Analysis of the adult human plasma metabolome Pharmacogenomics 9 2008 383 397
    • (2008) Pharmacogenomics , vol.9 , pp. 383-397
    • Lawton, K.A.1    Berger, A.2    Mitchell, M.3
  • 6
    • 0003484310 scopus 로고    scopus 로고
    • US Department of Health and Human Services Food and Drug Administration (FDA). May
    • US Department of Health and Human Services Food and Drug Administration (FDA). Guidance for industry: bioanalytical method validation. FDA Web site. http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/ Guidances/ucm070107.pdf. May 2001.
    • (2001) Guidance for Industry: Bioanalytical Method Validation


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.